Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.330
0.00 (0.00%)
At close: Mar 9, 2026, 4:00 PM EDT
1.340
+0.010 (0.75%)
After-hours: Mar 9, 2026, 4:54 PM EDT

Fate Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-136.32-186.26-160.93-281.72-212.15
Upgrade
Depreciation & Amortization
12.918.9618.2813.765.85
Upgrade
Other Amortization
--7.22.684
Upgrade
Loss (Gain) From Sale of Assets
0.010.94---
Upgrade
Asset Writedown & Restructuring Costs
-14.74---
Upgrade
Loss (Gain) From Sale of Investments
-3.61-9.08-11.4-0.265.07
Upgrade
Stock-Based Compensation
24.9241.543.4678.7354.36
Upgrade
Other Operating Activities
-0.26-1.71-48.06-26.69-22.09
Upgrade
Change in Accounts Receivable
2.62-1.1136.65-29.8-3.16
Upgrade
Change in Accounts Payable
-9.03-1.66-28.9414.255.91
Upgrade
Change in Other Net Operating Assets
2.660.8211.47-19.16-0.65
Upgrade
Operating Cash Flow
-106.08-122.87-132.26-248.21-162.87
Upgrade
Capital Expenditures
-5.95-0.73-6.15-35.57-50.7
Upgrade
Sale of Property, Plant & Equipment
0.36----
Upgrade
Investment in Securities
116.7612.95118.82202.32-273.32
Upgrade
Investing Cash Flow
111.1712.22112.67166.75-324.02
Upgrade
Issuance of Common Stock
-74.830.099.21432.45
Upgrade
Other Financing Activities
5.4925.07--20.68
Upgrade
Financing Cash Flow
5.4999.890.099.21453.13
Upgrade
Net Cash Flow
10.57-10.76-19.51-72.25-33.76
Upgrade
Free Cash Flow
-112.04-123.6-138.42-283.77-213.57
Upgrade
Free Cash Flow Margin
-1685.78%-906.79%-217.87%-294.68%-382.43%
Upgrade
Free Cash Flow Per Share
-0.94-1.09-1.41-2.93-2.25
Upgrade
Levered Free Cash Flow
-51.56-60.77-82.31-148.77-134.71
Upgrade
Unlevered Free Cash Flow
-51.56-60.77-82.31-148.77-134.71
Upgrade
Change in Working Capital
-3.74-1.9619.18-34.712.1
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.